Standout Papers

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2... 2016 2026 2019 2022 484
  1. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations (2016)
    Paolo Gionchetti, Axel Dignaß et al. Journal of Crohn s and Colitis

Citation Impact

6 from Science/Nature 102 standout
Sub-graph 1 of 20

Citing Papers

Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images
2023 StandoutScience
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
2021 Standout
2 intermediate papers

Works of Boris Vucelić being referenced

Fontolizumab (Huzaf), a humanized anti-IFN-gamma antibody, has clinical activity and excellent tolerability in moderate to severe Crohn’s disease
2004
[Acute psychoses caused by digitalis poisoning].
1994

Author Peers

Author Surgery Epidemiology Genetics Last Decade Papers Cites
Boris Vucelić 632 706 857 63 1.4k
I. Benfatto 1 30 173
Takuhei Hashimoto 539 24 4 16 1.2k
Christine Knauss 2 3 397
M.E. Gleave 31 11 42 22 406
Song‐Chwan Fang 4 8 9 14 444

All Works

Loading papers...

Rankless by CCL
2026